Quantum Technology Partners
13
17M
8
0.57
2
0.38
4
- Stages of investment
- Areas of investment
Summary
In 2000 was created Quantum Technology Partners, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the San Jose.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Quantum Technology Partners, startups are often financed by Vulcan Capital, PolyTechnos Venture Partners, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are PolyTechnos Venture Partners, Vulcan Capital, Canaan Partners. In the next rounds fund is usually obtained by Vulcan Capital, SCP Partners, PolyTechnos Venture Partners.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Medical. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Vaxart, StrataGent Life Sciences, Intelligent Medical Implants Ltd
The higher amount of exits for fund were in 2009. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2007. This Quantum Technology Partners works on 2 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 investment rounds annually.
The current fund was established by Barry Dickman. Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 2
- Exits
- 4
- Rounds per year
- 0.57
- Follow on index
- 0.38
- Investments by industry
- Health Care (7)
- Biotechnology (7)
- Manufacturing (6)
- Pharmaceutical (4)
- Semiconductor (3) Show 8 more
- Investments by region
-
- United States (12)
- Switzerland (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 125M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 2.11
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Vaxart | 14 Jan 2010 | Biotechnology, Health Care, Medical Device | Early Stage Venture | 3M | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.